Skip to content

Biomarkers and Postoperative Delirium in Elderly Patients

Relationship Between Neuroinflammatory Biomarkers and Postoperative Delirium in Elderly Patients With Hip Replacement

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05454228
Enrollment
400
Registered
2022-07-12
Start date
2022-07-01
Completion date
2024-12-31
Last updated
2023-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Delirium

Brief summary

This study intends to verify and explore the correlation of neuroinflammation biomarkers in cerebrospinal fluid and plasma of elderly patients undergoing hip replacement with postoperative delirium, so as to achieve a new method to predict whether patients will develop postoperative delirium and improve the prognosis of elderly patients with postoperative delirium. Reduce the probability of postoperative complications, improve the long-term survival rate of patients after surgery.

Interventions

BEHAVIORALpostoperative delirium

Postoperative delirium (POD) occurs within 1 week after surgery in patients, with obvious time characteristics, mainly occurring within 1-3 days after surgery. Postoperative delirium has adverse effects on the short and long term prognosis of patients. Patients with delirium have an increased risk of postoperative complications, perioperative death, longer hospital stay and increased medical costs during hospitalization.

Sponsors

Henan Provincial People's Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. age≥65 2. Patients undergoing hip replacement under spinal anesthesia 3. ASA grade I\ III; 4. Voluntarily participate in this study, and informed consent was signed by the patients themselves and their families

Exclusion criteria

1. Patients with multiple fractures and trauma 2. Patients with preoperative cognitive dysfunction determined by MMSE scale; 3. Severe impairment of hearing, visual and language system functions; 4. Not suitable for or unwilling to undergo subarachnoid anesthesia 5. Patients who refuse to participate or cannot cooperate.

Design outcomes

Primary

MeasureTime frameDescription
neuroinflammatory biomarkerspreoperative、24 hours after surgery、48 hours after surgeryWhether there are changes in neuroinflammatory biomarkers(Ykl40(pg/mL), procalcitonin(ng/mL), IL-17A,IL-23,INF-γ(IU), Tau(pg/mL), amyloid beta(pg/mL),etc) in cerebrospinal fluid and plasma between delirium patients and non-delirium patients before and after operation.

Countries

China

Contacts

Primary ContactZhaoyu Wen, Bachelor
76338445@qq.com0086-18860371522

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026